Clinical Trial Update: Epidemiology of Schizophrenia in Bulgaria

View source ↗

Summary

AstraZeneca-sponsored epidemiology study on schizophrenia in Bulgaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED